Source:http://linkedlifedata.com/resource/pubmed/id/10220857
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-7-7
|
pubmed:abstractText |
This study investigated the alterations that occur in auditory brainstem-evoked responses (ABRs) concurrent with changes in cochlear concentrations of glutathione (GSH), lipid peroxidation, and antioxidant enzyme activity in cisplatin-induced ototoxicity and in dose-dependent otoprotection by an antioxidant lipoate. Male Wistar rats were divided into different groups and were treated as follows, with: (1) vehicle (saline) control; (2) cisplatin (16 mg/kg, i.p.); (3) lipoate (100 mg/kg, i.p.) plus saline; (4) cisplatin plus lipoate (25 mg/kg); (5) cisplatin plus lipoate (50 mg/kg), and (6) cisplatin plus lipoate (100 mg/kg). Post-treatment ABRs were evaluated after three days, the rats were sacrificed, and cochleae were harvested and analyzed. The cisplatin-injected rats showed ABR threshold elevations above the pre-treatment thresholds. Rats treated with lipoate plus cisplatin did not show significant elevation of hearing thresholds. Cisplatin administration resulted in a depletion of cochlear GSH concentration (69% of control), whereas, cisplatin-plus-lipoate treatment increased GSH concentration close to control value. Cisplatin-treated rats showed a decrease in cochlear superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), and glutathione reductase (GR) activities (57, 78, 59, and 58% of control, respectively), and an increase in malondialdehyde (MDA) concentration (196% of control). Cochlear SOD, CAT, GSH-Px, and GR activities and MDA concentrations were restored in the rats injected with cisplatin plus graded doses of lipoate than those with cisplatin alone. It is concluded that cisplatin-induced ototoxicity is related to impairment of the cochlear antioxidant defense system, and the dose-dependent otoprotection conferred by an antioxidant lipoate against cisplatin ototoxicity is associated with sparing of the cochlear antioxidant defense system.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Free Radicals,
http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species,
http://linkedlifedata.com/resource/pubmed/chemical/Thioctic Acid
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1096-6080
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
195-202
|
pubmed:dateRevised |
2010-9-17
|
pubmed:meshHeading |
pubmed-meshheading:10220857-Animals,
pubmed-meshheading:10220857-Antineoplastic Agents,
pubmed-meshheading:10220857-Antioxidants,
pubmed-meshheading:10220857-Cisplatin,
pubmed-meshheading:10220857-Cochlea,
pubmed-meshheading:10220857-Dose-Response Relationship, Drug,
pubmed-meshheading:10220857-Drug Evaluation, Preclinical,
pubmed-meshheading:10220857-Evoked Potentials, Auditory, Brain Stem,
pubmed-meshheading:10220857-Free Radicals,
pubmed-meshheading:10220857-Lipid Peroxidation,
pubmed-meshheading:10220857-Male,
pubmed-meshheading:10220857-Rats,
pubmed-meshheading:10220857-Rats, Wistar,
pubmed-meshheading:10220857-Reactive Oxygen Species,
pubmed-meshheading:10220857-Thioctic Acid
|
pubmed:year |
1999
|
pubmed:articleTitle |
Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system.
|
pubmed:affiliation |
Department of Pharmacology, Southern Illinois University, School of Medicine, Springfield 62794, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|